NewGenIvf Group Limited (NASDAQ:NIVF) Sees Significant Increase in Short Interest

NewGenIvf Group Limited (NASDAQ:NIVF) was the target of a significant growth in short interest in the month of August. As of August 14th, there was short interest totaling 171,641 shares, a growth of 1,821.6% from the July 30th total of 8,932 shares. Based on an average daily volume of 608,157 shares, the short-interest ratio is currently 0.3 days. Currently, 4.3% of the shares of the company are sold short.

Insider Buying and Selling

In other NewGenIvf Group news, major shareholder Financial Lp Hrt sold 28,439 shares of the business’s stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $2.40, for a total transaction of $68,253.60. Following the transaction, the insider owned 18,187 shares of the company’s stock, valued at $43,648.80. The trade was a 60.99% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 31.80% of the company’s stock.

NewGenIvf Group Price Performance

NIVF stock traded up $0.05 during midday trading on Tuesday, reaching $0.55. The company had a trading volume of 482,235 shares, compared to its average volume of 669,116. The stock has a 50 day moving average price of $1.16 and a 200-day moving average price of $4.16. The company has a quick ratio of 2.98, a current ratio of 3.12 and a debt-to-equity ratio of 0.16. NewGenIvf Group has a 1-year low of $0.45 and a 1-year high of $513.00.

NewGenIvf Group shares are set to reverse split before the market opens on Tuesday, September 1st. The 1-3 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, August 31st.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. Weiss Ratings restated a “sell (d)” rating on shares of NewGenIvf Group in a research note on Friday, July 24th. Wall Street Zen raised shares of NewGenIvf Group to a “hold” rating in a research report on Saturday, July 4th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, NewGenIvf Group presently has an average rating of “Sell”.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.